Transcriptional control of adipogenesis

Annual Review of Nutrition

Volumn 20, Issue , 2000, Pages 535-559

  Rangwala, S M ^a   Lazar, M A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

ADD; Adipocyte differentiation; C EBP; Fat; PPAR; SREBP

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN;

ADIPOCYTE; CELL DIFFERENTIATION; DNA MODIFICATION; GENE TARGETING; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; TRANSCRIPTION REGULATION;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; CELL LINE; HUMANS; MICE; MODELS, MOLECULAR; OBESITY; TRANSCRIPTION FACTORS;

EID: 0033830783     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.20.1.535     Document Type: Review

References (165)

1. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site
2. PPARgamma induces cell cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A
3. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors
4. Coactivators for the orphan nuclear receptor RORalpha
5. Rosiglitazone
6. Highly specific and quantitative activation of STATs in 3T3-L1 adipocytes
7. PPAR gamma is required for placental, cardiac, and adipose tissue development
8. Expression of peroxisome proliferator-activated receptor PPARdelta promotes induction of PPARgamma and adipocyte differentiation in 3T3C2 fibroblasts
9. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: Binding and activation correlate with antidiabetic actions in db/db mice
10. Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects
11. Dual role of the basic helix-loop-helix transcription factor scleraxis in mesoderm formation and chondro-genesis during mouse embryogenesis
12. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
13. Differential activation of adipogenesis by multiple PPAR isoforms
14. Troglitazone action is independent of adipose tissue
15. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase
16. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells
17. Regulation of the C/EBP-related gene gadd 153 by glucose deprivation
18. Stable expression of functional mitochonddal uncoupling protein in Chinese hamster ovary cells
19. An adipogenic co-factor bound by the differentiation domain of PPARgamma
20. Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival
21. Peroxisome proliferator-activated receptor (PPAR) gamma: Adipose-predominant expression and induction early in adipocyte differentiation
22. Troglitazone: An antidiabetic agent
23. CCAAT/enhancer binding protein gene promoter: Binding of nuclear factors during differentiation of 3T3-L1 preadipocytes
24. Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCA-AT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes
25. Regulation of adipocyte development
26. Developmental profile of homeobox gene expression during 3T3-L1 adipogenesis
27. Differentiation of embryonic stem cells into adipocytes in vitro
28. The role of C/EBP genes in adipocyte differentiation
29. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
30. Nucleoprotein complexes that regulate gene expression in adipocyte differentiation: Direct participation of c-fos
31. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors
32. The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonic cancers
33. Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis
34. Increased gadd 153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide
35. PPARgamma3 mRNA: A distinct PPARgamma mRNA subtype transcribed from an independent promoter
36. Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: Implications for adipocyte differentiation and metabolism
37. The adipocyte: Storage depot or node on the energy information superhighway?
38. Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein alpha
39. Mitogen-activated protein kinase activation is not necessary for, but antagonizes, 3T3-L1 adipocytic differentiation
40. Upregulation of CHOP-10 (gadd153) expression in the mouse blastocyst as a response to stress
41. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta
42. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
43. Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells
44. Leptin and the regulation of body weight in mammals
45. Analysis of uncoupling protein and its mRNA in adipose tissue deposits of adult humans
46. Hormones: Leptin and diabetes in lipostrophic mice
47. Nuclear receptor coactivators
48. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor
49. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion
50. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells
51. Formation of normally differentiated subcutaneous fat pads by an established preadipose cell line
52. An established pre-adipose cell line and its differentiation in culture
53. Understanding adipocyte differentiation
54. A eukaryotic transcriptional repressor with carboxypeptidase activity
55. Thiazolidinediones
56. Functional antagonism between CCAAT/Enhancer binding protein-alpha and peroxisome proliferator-activated receptor-gamma on the leptin promoter
57. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma
58. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha
59. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in rat aortic smooth muscle cells
60. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
61. Derepression of the C/EBPalpha gene during adipogenesis: Identification of AP-2alpha as a repressor
62. Mouse insulin-responsive glucose transporter gene: Characterization of the gene and trans-activation by the CCAAT/enhancer binding protein
63. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes
64. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptorretinoid X receptor heterodimers
65. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1
66. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism
67. ADD1/SREBP-1 activates PPARγ through the production of endogenous ligand
68. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
69. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma
70. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
71. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance
72. Differentiation of 3T3-F442A cells into adipocytes is inhibited by retinoic acid
73. TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage
74. Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice
75. Biological role of the CCAAT/enhancer-binding protein family of transcription factors
76. The blockade of preadipocyte differentiation by protein-tyrosine phosphatase HA2 is reversed by vanadate
77. Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes
78. CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program
79. A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: Transcriptional activator lacking antimitotic activity
80. Sterol regulation of acetyl coenzyme A carboxylase: A mechanism for coordinate control of cellular lipid
81. Brown adipose tissue, beta 3-adrenergic receptors, and obesity
82. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue
83. TNFalpha disrupts mitotic clonal expansion and regulation of retinoblastoma proteins p130 and p107 during 3T3-L1 adipocyte differentiation
84. Transcriptional regulation of gene expression during adipocyte differentiation
85. Two tandem binding sites for sterol regulatory element binding proteins are required for sterol regulation of fatty-acid synthase promoter
86. Nuclear receptor coregulators: Cellular and molecular biology
87. FDA approves pioglitazone for diabetes
88. Life without white fat: A transgenic mouse
89. Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18 (INK4c) and p21 (Waf1/Cip1), during adipogenesis
90. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists
91. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma
92. Establishment of preadipocyte clonal line from epididymal fat pad of ob/ob mouse that responds to insulin and to lipolytic hormones
93. Relative roles of CCAAT/enhancer-binding protein beta and cAMP regulatory element-binding protein in controlling transcription of the gene for phosphoenolpyruvate carboxykinase (GTP)
94. Role of CCAAT enhancer-binding protein beta in the thyroid hormone and cAMP induction of phosphoenolpyruvate carboxykinase gene transcription
95. Transcriptional regulation by the gamma5 subunit of a heterotrimeric G protein during adipogenesis
96. Thiazolidinediones block tumor necrosis factor-α-induced inhibition of insulin signaling
97. Activation of PPARgamma coactivator-1 through transcription factor docking
98. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis
99. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system
100. A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor gamma-activating properties
101. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma
102. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
103. Obestity associated with a mutation in a genetic regulator of adipocyte differentiation
104. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription
105. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro
106. Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase
107. Targeted expression of a toxin gene to adipose tissue: Transgenic mice resistant to obesity
108. Activators of the nuclear receptor PPARgamma enhance colon polyp formation
109. Differentiation and reversal of malignant changes in colon cancer through PPARgamma
110. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene
111. Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter
112. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: Intermolecular synergy requires only the PPARgamma hormone-dependent activation function
113. Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription
114. Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: Regulation by peroxisome proliferatoractivated receptor gamma
115. The role of TNF alpha in adipocyte metabolism
116. Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation
117. Interdomain communication regulating ligand binding by PPAR-gamma
118. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a
119. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene
120. Cholesterol feeding reduces nuclear forms of sterol regulatory element binding proteins in hamster liver
121. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
122. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: Model for congenital generalized lipodystrophy
123. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells
124. Fine structural studies on white adipocyte differentiation
125. Transcriptional repression of pref-1 by glucocorticoids promotes 3T3-L1 adipocyte differentiation
126. Transcriptional control of the pref-1 gene in 3T3-L1 adipocyte differentiation. Sequence requirement for differentiation-dependent suppression
127. Adipogenesis and obesity: Rounding out the big picture
128. Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by antagonists of adipogenesis
129. PPARgamma ligand-dependent induction of STAT1, STAT5A, and STAT5B during adipogenesis
130. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha
131. Transcriptional repression of the C/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha: Regulations is coordinate and independent of protein synthesis
132. The molecular basis for inhibition of adipose conversion of murine 3T3-L1 cells by retinoic acid
133. cAMP Activation of CAAT enhancer-binding protein-beta gene expression and promoter I of acetyl-CoA carboxylase
134. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene
135. Repressive effect of Sp1 on the C/EBPalpha gene promoter: Role in adipocyte differentiation
136. Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation
137. As obesity rates rise, experts struggle to explain why
138. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine
139. CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein
140. PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene
141. mPPAR gamma 2: Tissue-specific regulator of an adipocyte enhancer
142. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipidactivated transcription factor
143. ADD1: A novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation
144. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
145. CCAAT-enhancer binding protein: A component of a differentiation switch
146. Impaired energy homeostasis in C/EBP alpha knockout mice
147. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis
148. Obesity: How big a problem?
149. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones
150. Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids
151. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1
152. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity
153. Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis
154. PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes
155. Transmembrane tumor necrosis factor (TNF)-alpha inhibits adipocyte differentiation by selectively activating TNF receptor 1
156. Distinct stages in adipogenesis revealed by retinoid inhibition of differentiation after induction of PPARgamma
157. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins
158. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene
159. Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma
160. Differential activation of peroxisome proliferator-activated receptors by eicosanoids
161. The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion
162. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha
163. Insulin-and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma
164. Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor
165. Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: Alternative promoter use and different splicing yield two mPPAR gamma isoforms